Fig. 1From: Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemiaFlowchart of the integrated strategy platform. Part 1: The mechanism of berberine (BBR) in the treatment of hyperlipidemia (HLP) was comprehensively described based on targeted lipidomics. Part 2: The network pharmacology approach was developed to identify targets of BBR for the treatment of HLP. Part 3: Potential links between biomarkers and hub genesBack to article page